Macrophage TLR4 and PAR2 Signaling: Role in Regulating Vascular Inflammatory Injury and Repair
- PMID: 33072072
- PMCID: PMC7530636
- DOI: 10.3389/fimmu.2020.02091
Macrophage TLR4 and PAR2 Signaling: Role in Regulating Vascular Inflammatory Injury and Repair
Abstract
Macrophages play a central role in dictating the tissue response to infection and orchestrating subsequent repair of the damage. In this context, macrophages residing in the lungs continuously sense and discriminate among a wide range of insults to initiate the immune responses important to host-defense. Inflammatory tissue injury also leads to activation of proteases, and thereby the coagulation pathway, to optimize injury and repair post-infection. However, long-lasting inflammatory triggers from macrophages can impair the lung's ability to recover from severe injury, leading to increased lung vascular permeability and neutrophilic injury, hallmarks of Acute Lung Injury (ALI). In this review, we discuss the roles of toll-like receptor 4 (TLR4) and protease activating receptor 2 (PAR2) expressed on the macrophage cell-surface in regulating lung vascular inflammatory signaling.
Keywords: PAR2; TLR4; acute lung injury; alveolar macrophages; inflammation; macrophage; vascular permeability.
Copyright © 2020 Rayees, Rochford, Joshi, Joshi, Banerjee and Mehta.
Figures


Similar articles
-
PAR2-Mediated cAMP Generation Suppresses TRPV4-Dependent Ca2+ Signaling in Alveolar Macrophages to Resolve TLR4-Induced Inflammation.Cell Rep. 2019 Apr 16;27(3):793-805.e4. doi: 10.1016/j.celrep.2019.03.053. Cell Rep. 2019. PMID: 30995477 Free PMC article.
-
Exosomes in postshock mesenteric lymph are key mediators of acute lung injury triggering the macrophage activation via Toll-like receptor 4.FASEB J. 2018 Jan;32(1):97-110. doi: 10.1096/fj.201700488R. Epub 2017 Aug 29. FASEB J. 2018. PMID: 28855278
-
Anti-inflammatory effect of Yam Glycoprotein on lipopolysaccharide-induced acute lung injury via the NLRP3 and NF-κB/TLR4 signaling pathway.Int Immunopharmacol. 2020 Apr;81:106024. doi: 10.1016/j.intimp.2019.106024. Epub 2019 Nov 26. Int Immunopharmacol. 2020. PMID: 31784404
-
Targeting TLR4 Signaling to Blunt Viral-Mediated Acute Lung Injury.Front Immunol. 2021 Jul 2;12:705080. doi: 10.3389/fimmu.2021.705080. eCollection 2021. Front Immunol. 2021. PMID: 34282358 Free PMC article. Review.
-
Targeting alveolar macrophages: a promising intervention for pulmonary infection and acute lung injury.Cell Mol Biol Lett. 2025 Jun 14;30(1):69. doi: 10.1186/s11658-025-00750-6. Cell Mol Biol Lett. 2025. PMID: 40517224 Free PMC article. Review.
Cited by
-
Dexmedetomidine Reduces Chronic Stress-Related Thrombosis in a Mouse FeCl3 Model.FASEB J. 2025 May 15;39(9):e70546. doi: 10.1096/fj.202500724R. FASEB J. 2025. PMID: 40304859 Free PMC article.
-
Metabolic Reprograming of Macrophages: A New Direction in Traditional Chinese Medicine for Treating Liver Failure.J Immunol Res. 2024 Dec 24;2024:5891381. doi: 10.1155/jimr/5891381. eCollection 2024. J Immunol Res. 2024. PMID: 39741958 Free PMC article. Review.
-
Dihydronicotinamide Riboside Is a Potent NAD+ Precursor Promoting a Pro-Inflammatory Phenotype in Macrophages.Front Immunol. 2022 Feb 25;13:840246. doi: 10.3389/fimmu.2022.840246. eCollection 2022. Front Immunol. 2022. PMID: 35281060 Free PMC article.
-
Effect of plasma homocysteine on cardiometabolic multimorbidity among Chinese adults: a population-based and real-world evidence study.Front Nutr. 2024 Dec 20;11:1522212. doi: 10.3389/fnut.2024.1522212. eCollection 2024. Front Nutr. 2024. PMID: 39758316 Free PMC article.
-
Macrophages clear out necrotic liver lesions: a new magic trick revealed.eGastroenterology. 2023 Sep 22;1(2):e100024. doi: 10.1136/egastro-2023-100024. eCollection 2023 Sep. eGastroenterology. 2023. PMID: 39944003 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources